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Activation of Myocardial Phosphoinositide-3-Kinase
p110a Ameliorates Cardiac Dysfunction and Improves
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Abstract
Phosphoinositide-3-kinase (PI3K)/Akt dependent signaling has been shown to improve outcome in sepsis/septic shock.
There is also ample evidence that PI3K/Akt dependent signaling plays a crucial role in maintaining normal cardiac function.
We hypothesized that PI3K/Akt signaling may ameliorate septic shock by attenuating sepsis-induced cardiac dysfunction.
Cardiac function and survival were evaluated in transgenic mice with cardiac myocyte specific expression of constitutively
active PI3K isoform, p110a (caPI3K Tg). caPI3K Tg and wild type (WT) mice were subjected to cecal ligation/puncture (CLP)
induced sepsis. Wild type CLP mice showed dramatic cardiac dysfunction at 6 hrs. Septic cardiomyopathy was significantly
attenuated in caPI3K CLP mice. The time to 100% mortality was 46 hrs in WT CLP mice. In contrast, 80% of the caPI3K mice
survived at 46 hrs after CLP (p,0.01) and 50% survived .30 days (p,0.01). Cardiac caPI3K expression prevented expression
of an inflammatory phenotype in CLP sepsis. Organ neutrophil infiltration and lung apoptosis were also effectively inhibited
by cardiac PI3k p110a expression. Cardiac high mobility group box–1 (HMGB-1) translocation was also inhibited by caPI3K
p110a expression. We conclude that cardiac specific activation of PI3k/Akt dependent signaling can significantly modify the
morbidity and mortality associated with sepsis. Our data also indicate that myocardial function/dysfunction plays a
prominent role in the pathogenesis of sepsis and that maintenance of cardiac function during sepsis is essential. Finally,
these data suggest that modulation of the PI3K/p110a signaling pathway may be beneficial in the prevention and/or
management of septic cardiomyopathy and septic shock.
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dysfunction as a consequence of sepsis has been termed ‘‘septic
cardiomyopathy’’ [5–7]. It is now well accepted that septic
cardiomyopathy is an emerging problem in the management of
the critically ill patient [5].
The phosphoinositide-3-kinases (PI3Ks) are a conserved family
of signal transduction enzymes which are involved in regulating
cellular proliferation and survival [8,9]. The PI3Ks and the
downstream serine/threonine kinase Akt (also known as protein
kinase B = PKB) regulate cellular activation, inflammatory responses, chemotaxis and apoptosis [9]. Guha and Mackman have
reported that the ‘‘PI3K-Akt pathway imposes a braking
mechanism to limit the expression’’ of pro-inflammatory mediators in LPS treated monocytes [10]. Using an in vivo sepsis model,
we have reported that PI3K inhibition increases susceptibility of
mice to polymicrobial sepsis [11]. Of greater significance, we have
demonstrated that stimulation of PI3K/Akt dependent signaling

Introduction
The critically ill patient frequently develops a complex disease
spectrum that may include acute respiratory distress syndrome
(ARDS), systemic inflammatory response syndrome (SIRS), sepsis
syndrome and/or septic shock and multi-organ dysfunction
syndrome (MODS) [1]. In the United States ,750,000 patients/
year develop sepsis syndrome [2]. The overall mortality rate is
28.6% (,215,000 deaths/year) [2]. Those patients that survive the
initial event may ultimately succumb to widespread organ
dysfunction that can be either acute, due to hyper-inflammatory
responses, or more prolonged due to immune dysfunction and
infection [3,4]. Indeed, sepsis is a frequent cause of MODS [3,4].
In many cases, the lung is the primary organ affected, however, it
is well known that cardiovascular dysfunction is also associated
with MODS morbidity and mortality [5–7]. Cardiovascular
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and tissue nuclear factor-kB (NFkB) analysis. For HMGB-1
analysis, tissue samples were harvested at 6 and 12 hrs after CLP.

increases survival outcome in sepsis [11]. In support of this
observation, Bommhardt et al reported that mice which constitutively over express active Akt in their lymphocytes showed
decreased lymphocyte apoptosis, a TH1 cytokine propensity, and a
marked improvement in survival outcome in response to sepsis
[12]. We and others have reviewed the role of PI3K in the
regulation of inflammatory and/or septic responses [13,14]. The
data suggest that PI3K/Akt may be an endogenous negative
feedback regulator and/or compensatory mechanism which is
crucial to the maintenance and integrity of homeostasis during
septic and/or inflammatory insults [13,14]. However, the mechanisms by which PI3K/Akt ameliorates septic sequelae and
improves survival outcome have not been fully delineated.
There is ample evidence that PI3k/Akt dependent signaling
plays a crucial role in cardiac function [15–17]. We have reported
that sepsis decreases myocardial Akt activation [18], which
positively correlates with cardiac dysfunction in sepsis. We also
reported that preventing sepsis induced changes in Akt activation
ameliorates cardiovascular dysfunction in sepsis [18]. Based on
these data, we hypothesized that activation of PI3K/Akt
dependent signaling will prevent or blunt cardiac dysfunction
during sepsis/septic shock. To test this hypothesis, we examined
the effect of sepsis/septic shock on cardiac function and survival in
transgenic mice with cardiac myocyte specific expression of a
constitutively active PI3K isoform p110a (caPI3K Tg).

Hemodynamic Measurements
Cardiovascular function was assessed as previously described by
our group [18]. Briefly, mice were anesthetized with isoflurane
inhalation and ventilated with room air using a rodent ventilator.
A microconductance pressure catheter (Millar Instruments Inc.,
Houston, TX) was positioned in the left ventricle (LV) via the right
carotid artery for continuous registration of LV pressure-volume
loops [24,25] using the PowerLab system (AD Instruments, Inc.,
Colorado Springs, CO). A cuvette calibration method was used to
convert the conductance voltage into volume units by filling
nonconductive cuvettes of known diameter with heparin treated
mouse blood. Parallel conductance from surrounding structures
was determined by intravenous (external jugular vein) injection of
a small bolus (15 ml) of hypertonic saline (15% NaCl). All
measurements were performed while ventilation was turned off
momentarily. Indices of systolic and diastolic cardiac performance
were derived from LV pressure-volume data obtained at steady
state.

Echocardiographic Analysis of Cardiac Function
Transthoracic two-dimensional M-mode echocardiograms were
obtained using a Toshiba Aplio 80 Imaging System (Tochigi,
Japan) equipped with a 12 MHz linear transducer. The mice were
anesthetized using a mixture of isoflurane (1.5%) and oxygen
(0.5 l/min) and the body temperature was maintained at ,37uC
using a heating pad. M-mode tracings were used to measure enddiastolic diameter (LVEDD). Percent fractional shortening (%FS)
and ejection fraction (%EF) were calculated as described [26]. All
echocardiographic assessments were performed by the same
investigator.

Materials and Methods
Experimental Animals
The caPI3K p110a transgenic mice, on the C47Bl/6J
background, were kindly provided by Dr. Seigo Izumo from
Harvard Medical School [19,20]. The mice were maintained and
bred in the Division of Laboratory Animal Resources at East
Tennessee State University (ETSU). The experiments outlined in
this manuscript conform with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85–23, revised 1996). The experimental protocols as well as all aspects of animal care described in
this manuscript were reviewed and approved by the ETSU
Committee on Animal Care.

Western Blot
Cytoplasmic proteins were isolated from heart, liver, lung and
spleen. Immunoblots were performed as described previously [27–
31]. Briefly, the cellular proteins were separated by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and
transferred onto Hybond ECL membranes (Amersham Pharmacia, Piscataway, NJ). The ECL membranes were incubated with
appropriate primary antibody against anti-phospho-Akt, or antiAkt; anti-phospho-GSK3b or anti-GSK3b respectively, followed
by incubation with peroxidase-conjugated second antibodies (Cell
Signaling Technology, Inc. Beverly, MA). The membranes were
analyzed by the ECL system (Amersham Pharmacia). The same
membranes were stripped and re-probed with anti-GAPDH
(glyceraldehyde-3-phosphate dehydrogenase, Biodesign, Saco,
Maine) as loading controls. In the case of nuclear HMGB-1,
histone 3 was employed as the loading control. The signals were
quantified by scanning densitometry and computer-assisted image
analysis.

Cecal Ligation and Puncture (CLP)
Cecal ligation and puncture was performed to induce sepsis in
mice as previously described [21–23]. Briefly, the mice were
anesthetized by isoflurane inhalation and ventilated with room air
using a rodent ventilator. A midline incision was made on the
anterior abdomen and the cecum was exposed and ligated with a 0
suture. Two punctures were made through the cecum with an 18gauge needle and feces were extruded from the holes. The
abdomen was then closed. Fluid resuscitation (1 ml lactated
Ringers) was administered subcutaneously after surgery. Sham
surgical operated mice (anesthesia and laparotomy) served as the
surgical control group. Mice that were not subjected to surgery or
anesthesia served as the normal controls.

Assessment of Serum Cytokine Levels
Four to six mice from each group were euthanized at 16 hrs
after surgery and the serum was harvested. The serum was stored
in liquid nitrogen until assayed. Serum cytokine levels were
assayed with an Invitrogen murine 20 plex cytokine assay
(Carlsbad, CA) on a Luminex 100 instrument. Specifically, we
assayed the serum for fibroblast growth factor basic (FGFb),
granulocyte macrophage colony stimulating factor (GM-CSF),
interferon-c (IFN-c), interleukin-1a (IL-1a), interleukin-1b (IL-1b),
interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-5 (IL-5),

Experimental Protocol
Mice were subjected to either CLP or sham surgery at time 0.
Cardiovascular function was assessed at 6 hrs post-CLP. In a
separate experiment, the same groups were followed for survival
and at 16 hrs representative post-CLP mice were taken from each
group, euthanized and serum and tissues were harvested for
analysis of serum cytokines/chemokines, Akt and glycogen
synthase kinase-3b (GSK3b) phosphorylation, tissue apoptosis
PLOS ONE | www.plosone.org
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interleukin-6 (IL-6), interleukin-10 (IL-10), interleukin-12 p40/p70
(IL-12p40/p70), interleukin-13 (IL-13), interleukin-17 (IL-17),
interferon inducible protein-10 (IP-10), keratinocyte chemoattractant (KC), monocyte chemotactic protein-1 (MCP-1), macrophage
inflammatory protein-1a (MIP-1a), monokine induced by interferon-c (MIG), tumor necrosis factor a (TNFa) and vascular
endothelial growth factor (VEGF). Cytokine levels were established by comparison to a standard curve as per the manufacturer’s instructions.

Results
Cardiac Specific Expression of Constitutively Active PI3K
p110a Attenuates Sepsis Induced Cardiac Dysfunction
We examined the effect of sepsis on cardiac function in caPI3K
mice using two approaches. First, we examined cardiac function
using a conductance catheter as previously described [24,25,18].
Second, we employed echocardiography as a non-invasive
approach to assess cardiac function in septic mice. Cardiac
function was assessed at 6 hrs after CLP induced sepsis. As
expected, WT mice subjected to CLP showed significant
depression of cardiac function (Table 1 and Figure 1). Cardiac
output was reduced by 78.5%, stroke work by 73.7%, dp/dt max
(mmHg/sec) by 47.6%, and ejection fraction by 45.7%, respectively, compared with sham control (Figure 1). However, cardiac
dysfunction was attenuated in response to sepsis in mice with
cardiac specific expression of constitutively active PI3K p110a,
(Table 1 and Figure 1). In some cases, expression of the PI3k
p110a transgene resulted in a maintenance of normal cardiac
function in response to sepsis (Figure 1). Specific examples
include cardiac output, dP/dt max, stroke work, ejection fraction,
maximum elastance (Emax) and regression of log (pressure) versus
time (Tau-Weiss) (Figure 1 and Table 1). End systolic pressure,
end systolic volume and stroke volume in caPI3K CLP mice were
maintained at levels significantly higher than the WT CLP mice,
but they were significantly different from the sham controls.
Echocardiographic analysis confirmed that caPI3K Tg mice
showed attenuation of cardiac function in response to CLP sepsis
(Table 2). Left ventricular end systolic diameter (LVESD) was
significantly increased, while %FS and ejection fraction (%EF)
were significantly decreased in WT CLP mice, when compared to
WT sham and caPI3K CLP groups (Table 2). Interestingly,
LVEDD did not change in response to CLP sepsis, but in the
caPI3K-CLP group LVEDD was significantly lower than either
the caPI3K-sham or WT-CLP groups (Table 2). There was no
significant difference in LVESD, %FS and EF between caPI3Ksham and caPI3K-CLP groups.

Splenocyte Apoptosis
We employed two approaches to assess splenocyte apoptosis in
response to sepsis. First, in situ cardiac splenocyte apoptosis was
examined by the TdT mediated dUTP nick end labeling
(TUNEL) assay (Boehringer Mannheim, Indianapolis, IN) as
described previously [24]. Three slides from each block were
evaluated for apoptotic cells using the TUNEL assay. Tunel stains
were imaged using a fluorescent microscope. In addition, four slide
fields were randomly examined using a defined rectangular field
area with 200X magnification. Apoptotic cells were counted in
each field. Second, spleens were harvested into ice cold phosphate
buffered saline (PBS) 16 hrs after induction of CLP. Individual
cells were isolated by teasing the stroma apart with needles,
allowing the stroma to settle, and pouring the suspended cells into
a fresh tube. The red blood cells were lysed with hypotonic saline.
The leukocytes were fixed with ice cold 70% ethanol for at least
18 h at 220uC. The cells were washed three times with PBS, and
then stained with 50 mg/ml propidium iodide with 10 mg/ml
RNase A for 30 min at 37uC. The samples were then analyzed for
the sub G0 population using a FACScalibur flow cytometer with
CellQuest software (BD Biosciences, Mountain View, CA).

Tissue Myeloperoxidase (MPO) Activity
Lung tissue was processed as directed by the MPO Fluorometric
Detection Kit (Assay Designs, Ann Arbor, MI). Specifically, 50 mg
of tissue was weighed out into 1X assay buffer containing 10 mM
N-ethylmaleimide (Sigma). The tissue samples were homogenized
with a Polytron. After pelleting, the cells were lysed using 0.5%
hexadecyltrimethylammonium in 1X assay buffer. Following
homogenization and sonication at 50% power for 3–10 s pulses,
the homogenates were subjected to two freeze thaw cycles. After
clearing of cell debris by centrifugation, the lysates were stored at
280uC until assayed. The samples were assayed according to kit
directions and were read using the Modulus Microplate fluorescent plate reader after 30 min incubation (Turner Biosystems,
Sunnyvale, CA).

Cardiac Specific Expression of Constitutively Active PI3K
p110a Results in Increased Survival Outcome in CLP
Sepsis
To investigate whether preservation of cardiac function during
sepsis/septic shock will alter survival outcome, we performed CLP
to induce sepsis/septic shock in caPI3K (p110a) mice (n = 10).
Age-matched wild type (WT) mice (n = 10) served as control. As
shown in Figure 2, caPI3K mice were more resistant to CLPinduced mortality than WT mice. The median survival time in
WT mice was ,28 hrs and time to 100% mortality was 46 hrs. In
striking contrast, 90% of the caPI3K mice were alive at ,28 hrs
and 80% of the caPI3K mice survived at 46 hrs after CLP
(Figure 2). Of greater significance, 50% of the caPI3K mice went
on to survive indefinitely (.30 days) after CLP.

Tissue NFkB Assay
Nuclear protein was isolated from lung tissues according to
previously published methods [21]. Nuclear protein was assayed
for NFkB activity using a commercially available kit (Pierce
Thermo Scientific, Rockford, IL) according to the manufacturer’s
instructions.

Constitutive Activation of Myocardial PI3K p110a Results
in Increased Phosphorylation of Akt in the Myocardium,
but not Other Tissues

Statistics
Survival trends were compared with the log-rank Wilcoxon
non-parametric procedures. Phosphorylation, caspase and cytokine levels were summarized by the group mean. Using replicate
averages for each animal, group means were statistically compared
with the one-way analysis of variance (ANOVA) followed by the
least significant difference test. Unless otherwise stated data are
expressed as mean + s.e.m. A probability level of 0.05 or smaller
was used to report statistical significance.
PLOS ONE | www.plosone.org

Akt is a downstream target of PI3K [9]. Akt is activated by
phosphorylation [9]. We examined the levels of myocardial Akt
phosphorylation as well as total Akt levels in control and septic
mice (Figure 3A). Phosphorylated Akt levels were increased in the
myocardium of normal control, sham control and CLP mice
expressing the p110a transgene, when compared to WT mice
(Figure 3A). Interestingly, we did not see any significant
3

September 2012 | Volume 7 | Issue 9 | e44712

PI3k p110a Ameliorates Septic Cardiomyopathy

Figure 1. Cardiac myocyte specific expression of PI3K p110a attenuated cardiac dysfunction in CLP-induced septic mice. We
performed hemodynamic and echocardiographic analysis at 6 hrs after CLP. Echocardiography confirmed that cardiac function was compromised in
WT CLP. In contrast, caPI3K mice with CLP induced sepsis showed an overall maintenance of cardiac function. The bar graphs show the cumulative
cardiac function data for the respective control and experimental groups. Six hrs after CLP, left ventricular hemodynamic parameters were examined.
N = 5 mice/group. * p,0.05 compared to age-matched WT control. **p,0.05 compared to WT CLP group.
doi:10.1371/journal.pone.0044712.g001

difference in myocardial Akt phosphorylation in p110a transgenic
mice in the presence or absence of sepsis, however, sepsis did result
in a significant decrease in myocardial Akt phosphorylation in wild
type mice. We also examined Akt phosphorylation in the liver,

lung and spleen of caPI3K Tg mice in the presence and absence of
sepsis. We did not find any differences in Akt phosphorylation in
organs other than the heart in the presence or absence of sepsis
(data not shown). These data indicate that constitutive activation

Table 1. Cardiac myocyte specific expression of PI3K p110a significantly attenuated cardiac dysfunction in caPI3K mice with CLP
induced polymicrobial sepsis.

Hemodynamic parameter

Wild Type Sham

Wild Type CLP

Heart rate (beats/min)

419.7647.4

280.2650.6

End systolic pressure (mmHg)

93.6611.16

77.6617.21

1

caPI3K Sham

caPI3K CLP

441.8682.8

552.367.82,3

96.967.8

104.1615.12

End diastolic pressure (mmHg) 3.360.8

2.460.3

4.261.8

3.461.4

End systolic volume (ml)

37.067.6

28.963.8

38.963.5

28.561.93

End diastolic volume (ml)

66.463.4

37.962.91

69.063.4

48.863.82,3

32.363.3

10.163.0

1

34.463.2

22.869.72,3

Emax (mmHg/ml)

19.166.4

7.861.7

1

12.764.6

15.362.82

Tau-Weiss (ms)

6.461.3

12.062.51

7.260.9

7.262.72

Stroke volume (ml)

Data are presented as mean 6 SD.
1
p,0.05 vs wild type sham group.
2
p,0.05 vs wild type CLP group.
3
p,0.05 vs caPI3K sham group.
N = 5–6/group.
doi:10.1371/journal.pone.0044712.t001
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Table 2. Echocardiographic analysis indicates that caPI3K mice maintain cardiac function in response to CLP sepsis.

Parameters

Wild Type Sham (n = 5)

Wild Type CLP (n = 5)

1

2.1660.19

2.7860.14

2

3.6560.14

3.5660.12

LVESD (mm)

LVEDD (mm)

% fractional shortening
Ejection fraction

40.8362.9
72.3063.65

3

caPI3K Sham (n = 6)

caPI3K CLP (n = 6)

2.3660.3

2.0360.224,5

3.6760.25

3.1860.274,5

21.9963.82

3

35.7865.80

36.1265.124

44.9063.64

3

65.5667.78

66.7866.454

Data are presented as mean 6 SD.
1
left ventricular end systolic diameter.
2
left ventricular end diastolic diameter.
3
p,0.05 vs wild type sham group.
4
p,0.05 vs wild type CLP group.
5
p,0.05 vs caPI3K sham group.
N = 5–6/group.
doi:10.1371/journal.pone.0044712.t002

of myocardial PI3K p110a inactivates GSK3b in the myocardium.
Interestingly, we did not see any significant difference in
myocardial GSK3b phosphorylation in p110a transgenic mice
in the presence or absence of sepsis. We also examined the
phosphorylation of GSK3b in tissues other than the heart. There
were no differences in GSK3b phosphorylation in tissues other
than the heart, i.e. liver, lung and spleen (data not shown), in the
presence or absence of sepsis. These data indicate that constitutive
activation of myocardial PI3K p110a inactivates GSK3b in the
myocardium in the presence or absence of sepsis, but it does not
appear to inactivate GSK3b in extra-cardiac tissues.

of myocardial PI3K p110a activates Akt in the myocardium, but it
does not appear to activate Akt in extra-cardiac tissues. This is
consistent with previous observations indicating that the effect of
the transgene is limited to the heart [20].

Constitutive Activation of Myocardial PI3K p110a Results
in Increased Phosphorylation of GSK3b in the
Myocardium, but not Other Tissues
Activated Akt phosphorylates several downstream targets of the
PI3K pathway including glycogen synthase kinase-3b (GSK3b)
[32,33]. GSK3b is a crucial regulator of many cellular functions,
including cell survival and apoptosis [32]. GSK3b is a constitutively active enzyme that is inactivated by Akt via phosphorylation
of serine 9 [32]. The levels of phosphorylated GSK3b were
increased in the myocardium of normal control, sham control and
CLP mice expressing the p110a transgene when compared to WT
mice (Figure 3B). These data indicate that constitutive activation

Serum Cytokine/chemokine Levels are Maintained at
Normal Levels in Septic Mice with Cardiac Specific
Expression of PI3K p110a
We examined serum cytokine/chemokine levels at 16 hrs after
induction of CLP sepsis (Figs. 4 and 5). As previously reported,

Figure 2. Cardiac myocyte specific expression of PI3K p110a significantly improves survival outcome in CLP-induced sepsis/septic
shock. caPI3K transgenic mice (N = 10) and age-matched wild type mice (N = 11) were subjected to CLP at time 0. The mice were followed for survival
for up to 30 days.
doi:10.1371/journal.pone.0044712.g002

PLOS ONE | www.plosone.org
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Figure 3. Constitutive activation of myocardial PI3K p110a results in increased phosphorylation of Akt and GSK3b in the
myocardium. A. Akt phosphorylation is increased in the myocardium of caPI3K Tg mice, when compared to WT mice. Six hrs after CLP, the hearts
were harvested and cellular proteins were examined for levels of phospho-Akt/Akt. *p,0.05 compared with indicated group. (n = 6/group). B.
Expression of constitutively active PI3K p110a increases myocardial GSK3b phosphorylation in caPI3K mice. caPI3K mice and age-matched WT mice
were subjected to CLP. Six hrs after CLP, the hearts were harvested and cellular proteins were examined for levels of phospho-GSK3b. *p,0.05
compared with indicated group. (n = 6/group).
doi:10.1371/journal.pone.0044712.g003

CLP sepsis resulted in a significant increase in serum cytokine
levels at 16 hrs post-surgery (Figs. 4 and 5). In striking contrast,
expression of cardiac specific PI3K p110a had a dramatic effect on
CLP induced serum cytokine levels. Serum cytokine/chemokine
levels were maintained at normal levels in caPI3K CLP mice
(Figs. 4 and 5). Specifically, serum IL-1a, IL-5, IL-6, IL-12, IL17, TNFa, IFN-c, IP-10, MCP-1, MIG and MIP-1a levels in

PLOS ONE | www.plosone.org

caPI3K Tg mice were not significantly different from control and
sham mice (Figs. 4 and 5). These data indicate that septic
caPI3K Tg mice show a predominantly normal inflammatory
profile, when compared to WT CLP mice. No significant changes
were observed in IL-1b, IL-2, IL-4, IL-13, GM-CSF, FGFbasic or
GM-CSF in caPI3K Tg mice in the presence or absence of sepsis
(data not shown).
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Figure 4. Cardiac specific expression of PI3K p110a attenuates serum cytokine expression during CLP sepsis. caPI3K Tg mice and agematched WT mice were subjected to CLP. Sixteen hours after CLP the mice were euthanized, serum was harvested and analyzed for cytokine/
chemokine levels. *p,0.05 vs WT control; **p,0.05 vs WT sham surgery; #p,0.05 vs WT CLP. (n = 4–6/group).
doi:10.1371/journal.pone.0044712.g004

elevated when compared to control and sham control mice
(Fig. 5).

Attenuation of Serum KC Levels in Septic Mice with
Cardiac Specific Expression of PI3K p110a
KC is the murine equivalent of human IL-8, a neutrophil
chemoattractant and activator [34]. We observed that CLP in WT
mice significantly increased serum KC levels (Fig. 5). However,
septic mice with cardiac specific expression of PI3K p110a showed
attenuation (Q49.4%) of serum KC levels. Despite this attenuation, serum KC levels in the caPI3K mice were significantly
PLOS ONE | www.plosone.org

Attenuation of CLP Induced NFkB Activation in caPI3K
Mice
Sepsis induced activation of tissue NFkB activity is associated
with increased morbidity and mortality [21]. NFkB is also known
to play a pivotal role in the regulation of cytokine/chemokine
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Figure 5. Cardiac specific expression of PI3K p110a attenuates serum cytokine expression during CLP sepsis. caPI3K Tg mice and agematched WT mice were subjected to CLP. Sixteen hours after CLP the mice were euthanized, serum was harvested and analyzed for cytokine/
chemokine levels. *p,0.05 vs WT control; **p,0.05 vs WT sham surgery; #p,0.05 vs WT CLP; +p,0.05 vs caPI3K control; @p,0.05 vs caPI3K sham
surgery control. (n = 4–6/group).
doi:10.1371/journal.pone.0044712.g005

expression [35]. The data in Figures 4 and 5 indicate that
caPI3K mice do not show a pro-inflammatory phenotype. This
observation prompted us to examine organ NFkB activity in
caPI3K mice in response to CLP sepsis. As expected, WT mice
showed a significant increase in lung and spleen NFkB activity in
response to sepsis (Figure 6A and 6B). However, lung and spleen
tissue from mice expressing the p110a transgene did not show
nuclear translocation of NFkB components in response to sepsis
(Figure 6A and B). Surprisingly, we did not see any change in
cardiac NFkB activity in the presence or absence of sepsis (data
not shown). Thus, the NFkB confirms and extends the cytokine/

PLOS ONE | www.plosone.org

chemokine data which indicates that caPI3K mice show a
predominantly normal phenotype with respect to inflammatory
mediators.

Attenuation of Tissue MPO Activity in Septic caPI3K Mice
Neutrophil accumulation and degranulation in organs during
CLP sepsis is thought to mediate some of the pathophysiology of
this devastating disease [36]. Even though caPI3K mice showed
attenuation of serum KC levels, a neutrophil chemo-attractant, in
response to sepsis, it was noted that KC levels were higher in septic
caPI3K mice than in control or sham caPI3k mice (Fig. 5). To
8
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Figure 6. Cardiomyocyte expression of the p110a transgene attenuated tissue NFkB activity in response to CLP sepsis. Lung (A) and
spleen (B) NFkB activity are shown at the top. caPI3K mice and age-matched WT mice were subjected to CLP. Lung tissue was harvested 16 hrs after
CLP. *p,0.05 vs WT control; **p,0.05 vs WT CLP group. (n = 4/group). Cardiac specific expression of PI3K p110a attenuated myeloperoxidase activity
in the heart (C) and lung (D) in response to sepsis. caPI3K mice and age-matched WT mice were subjected to CLP. Heart and lung tissue was
harvested 16 hrs after CLP. (n = 4–6/group). *p,0.05 vs WT; **p,0.05 vs caPI3k control; #p,0.05 vs WT CLP; +p,0.05 vs caPI3k sham. E. Lung caspase
3/7 activity was increased in wild type, but not caPI3K Tg, mice in response to CLP sepsis. caPI3K mice and age-matched WT mice were subjected to
CLP. Lung tissue was harvested 16 hrs after CLP. (n = 4–6/group). *p,0.05 vs WT control; **p,0.05 vs WT CLP group.
doi:10.1371/journal.pone.0044712.g006
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evaluate the effect of transgenic p110a on neutrophils in sepsis, we
examined tissue MPO activity as an indicator of tissue neutrophil
infiltration and accumulation [37]. Tissue MPO activity was
increased in the heart and lung of WT CLP mice at 16 hrs after
surgery (Fig. 6C and D). MPO activity in the heart of caPI3K
mice was not significantly elevated in response to sepsis and it was
significantly lower than the MPO levels in the WT CLP
myocardium, indicating that expression of the p110a transgene
prevented neutrophil accumulation in the heart. MPO activity was
also significantly elevated in the lungs of WT mice at 16 hrs after
CLP, indicating neutrophil accumulation (Figure 6D). Lung
MPO activity was 27.4% lower (p,0.05) in septic caPI3K mice,
when compared to the WT CLP mice. However, lung MPO
activity in septic caPI3K Tg mice was increased (p,0.05) when
compared to caPI3K Tg sham control mice (Fig. 6D), indicating
that myocardial expression of the p110a transgene can attenuate,
but did not completely prevent, neutrophil accumulation in the
lung.

Cardiac Specific Expression of PI3k p110a Prevented
Activation of Tissue Caspase 3/7 and 8 in CLP Mice
Apoptosis is thought to play a significant role in pathophysiology
of sepsis [38]. PI3K signaling has been reported to be a prosurvival, anti-apoptotic pathway [11,12]. We examined caspase 3/
7 and 8 as indicators of the intrinsic and extrinsic apoptotic
signaling pathways. CLP significantly increased lung caspase 3/7
activity at 16 hrs (Figure 6E). However, caPI3K Tg mice showed
no change in caspase 3/7 activity in response to CLP (Figure 6E).
We did not detect any significant difference in lung caspase 8
activity (data not shown). We did not detect changes in heart or
liver apoptosis in response to CLP.
Figure 7. Expression of cardiac specific PI3K p110a did not
significantly alter splenocyte apoptosis in response to CLP
sepsis. Splenocytes were harvested 16 h after induction of CLP sepsis.
Splenocyte apoptosis was assessed by TUNEL staining (A) and flow
cytometry (B). *p,0.05 vs control or sham treatment. N = 4–6/group.
doi:10.1371/journal.pone.0044712.g007

Cardiac Specific Expression of the p110a Transgene did
not Alter Splenocyte Apoptosis in Response to CLP
Sepsis
We [11] and others [12] have reported that CLP sepsis induces
splenocyte apoptosis. Activation of PI3K/Akt dependent signaling
has been reported to attenuate splenocyte apoptosis in sepsis
[11,12]. In this study we examined splenocyte apoptosis at 16 hrs
post-CLP. We examined apoptosis by TUNEL staining of splenic
tissue (Figure 7A) and flow cytometry of isolated splenocytes
(Figure 7B). As expected, CLP sepsis significantly increased
splenocyte apoptosis in WT mice. Mice expressing the cardiac
specific p110a transgene showed comparable levels of splenocyte
apoptosis with both methods, indicating that cardiac specific
expression of PI3K p110a did not alter sepsis induced splenocyte
apoptosis (Figure 7A and B).

Discussion
In this study we found that constitutive activation of myocardial
PI3K p110a dramatically attenuates the cardiac dysfunction
associated with polymicrobial sepsis. We critically examined a
broad range of cardiac functional parameters in order to better
understand the role of myocardial PI3K p110a activation in the
attenuation of cardiac dysfunction during sepsis. As shown above,
cardiac output was dramatically reduced in wild type mice in
response to sepsis, suggesting inadequate perfusion of vital organs
as well as inadequate blood return to the left ventricle. However,
septic caPI3K mice showed higher heart rates, although a smaller
stroke volume was observed in these mice. The decrement in
stroke volume was offset by the higher heart rate in septic caPI3K
mice resulting in cardiac output that was maintained at normal
levels. The data also indicate that blood return to the heart was
maintained at or near normal levels in septic caPI3K mice. In
response to sepsis, wild type mice showed significant decreases in
left ventricular contractility. In contrast, constitutive activation of
PI3K p110a in cardiac myocytes resulted in left ventricular
contractility that was maintained at normal levels during sepsis.
We also observed that myocardial activation of PI3K p110a
maintained normal compliance of the left ventricle during sepsis,
while ventricular wall stiffness was markedly increased in septic
wild type mice. It was also noted that in contrast to wild type mice,

Cardiac Specific Expression of PI3K p110a Inhibits Sepsis
Induced Release of HMGB-1 from the Nucleus to the
Cytoplasm in Cardiac Myocytes
HMGB-1 is a late mediator of septic sequelae that is released
from the nucleus into the cytosol and systemic circulation in
response to various stimuli including sepsis [39–42]. We examined
the effect of myocardial caPI3K on release of nuclear HMGB-1 in
cardiac myocytes in response to CLP sepsis (Figure 8). We
examined two time intervals, six (top) and twelve (bottom) hours
after CLP. As expected, WT CLP mice showed a loss of nuclear
HMGB-1 and an increase in cytoplasmic levels at both time
intervals (Figure 8). In striking contrast, caPI3K mice, subjected
to CLP sepsis, showed no significant translocation of HMGB-1
from the nucleus to the cytoplasm.
PLOS ONE | www.plosone.org
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Figure 8. Cardiac specific expression of PI3K p110a inhibits HMGB-1 release from the nucleus to the cytoplasm in cardiac myocytes.
Nuclear and cytoplasmic HMGB-1 levels are shown at 6 (top) and 12 hrs (bottom) after CLP. caPI3K Tg mice and age-matched WT mice were
subjected to CLP. Six and twelve hours after CLP the mice were euthanized and nuclear and cytoplasmic protein was harvested. HMGB-1 was
assessed by Western blot. *p,0.05 WT CLP vs WT sham control or caPI3k CLP. N = 4–6/group.
doi:10.1371/journal.pone.0044712.g008

transgene was primarily observed in the heart and that the
systemic effect is due to an overall maintenance of left ventricular
cardiac function during sepsis. Activated Akt phosphorylates
several downstream targets of the PI3K pathway including
GSK3b [32,33]. GSK3b is a crucial regulator of many cellular
functions, including cell survival and apoptosis [32]. GSK3b is a
constitutively active enzyme that is inactivated by Akt via
phosphorylation of serine 9 [32]. We found that constitutive
activation of myocardial PI3K p110a increased the levels of
phosphorylated GSK3b, indicating inhibition of this enzyme in
the myocardium. Inhibition of myocardial GSK3b positively
correlated with maintenance of cardiovascular function and
improved survival outcome in CLP sepsis.
The precise role of circulating cytokines in the pathophysiology
of sepsis/septic shock is controversial and there is no definitive
cause-and-effect relationship between systemic cytokine levels and
survival outcome in sepsis [43]. Nevertheless, an examination of
circulating cytokines can provide valuable information on the
inflammatory and immunologic phenotype in response to CLP
sepsis [11]. Our data clearly show that cardiac specific expression

constitutive activation of cardiomyocyte PI3K p110a resulted in
left ventricular elastance and compliance that was maintained at
normal levels, thus preserving normal left ventricular function
during sepsis. When taken together, these data indicate that sepsis
negatively impacts a broad range of left ventricular functional
parameters. However, myocardial activation of PI3K p110a
prevents or significantly attenuates many of the deleterious effects
of polymicrobial sepsis on left ventricular function. The overall
maintenance of cardiac function in caPI3K mice strongly
correlates with decreased morbidity, attenuation of the proinflammatory phenotype and improved survival outcome in sepsis.
Akt (aka = protein kinase B) is an important downstream target
of PI3K [9,33]. In this study we observed that sepsis attenuated
myocardial Akt phosphorylation in wild type mice, but not caPI3k
Tg mice. Furthermore, Akt phosphorylation (activation) was only
increased in the myocardium of caPI3k Tg mice. Therefore, the
effect of the p110a transgene did not significantly influence Akt
phosphorylation at extra-cardiac sites. This is consistent with
previous reports using the PI3K transgenic mice [20]. Based on
these data it is reasonable to conclude that the effect of the
PLOS ONE | www.plosone.org
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of PI3K p110a prevents cytokine/chemokine over expression in
response to sepsis. Indeed, serum cytokine/chemokines in caPI3K
mice remained at control levels in response to sepsis. Therefore,
caPI3K did not show a pro-inflammatory phenotype in response
to sepsis. These data also indicate that we did not see a shift from
the Th1 to the Th2 phenotype that is frequently associated with
fulminating sepsis [44]. These results also indicate that constitutive
activation of p110a inhibited myocardial translocation of
HMGB1. HGMB1 is thought to play a role in mediating organ
damage in severe sepsis [41,40]. It is reasonable to speculate that
the effects of myocardial caPI3K p110a on HMGB-1 may
contribute to the protective mechanism. An intriguing aspect of
this investigation is that the PI3k p110a transgene was only
expressed in cardiomyocytes and is not expressed in immune
competent cells, such as macrophages, neutrophils and lymphocytes. Based on the current model of sepsis, it would have been
reasonable to expect that macrophages and other immunocytes
from caPI3K mice would respond normally to CLP sepsis by
releasing pro-inflammatory mediators with a subsequent shift to a
pro-inflammatory phenotype. This should have occurred irrespective of the PI3K p110a transgene effect in the heart. However, our
data clearly indicate that this did not occur. Therefore, our data
suggest that the current dogma regarding how immune competent
cells respond during sepsis may not be entirely accurate.
Specifically, our data suggest that maintaining left ventricular
function during sepsis may improve perfusion of the peripheral
vasculature and thereby attenuate the systemic inflammatory
response.
Activation of tissue NFkB activity is associated with increased
morbidity and mortality in CLP sepsis [21,45]. Furthermore, we
have reported that blunting tissue NFkB nuclear translocation will
reduce morbidity and enhance survival outcome in CLP sepsis
[45]. NFkB is also known to play a pivotal role in the regulation of
cytokine/chemokine expression during septic sequelae [45]. As
expected, WT mice showed a significant increase in lung NFkB
activity in response to sepsis, which correlated with a strong proinflammatory response and rapid mortality. However, lung and
splenic tissue from mice expressing the p110a transgene did not
show nuclear translocation of NFkB components in response to
sepsis. Not surprisingly, the NFkB data confirms and extends the
cytokine/chemokine data, indicating that caPI3K mice show a
predominantly normal inflammatory phenotype in response to
sepsis.
Tissue neutrophil infiltration, adhesion and degranulation are
thought to play a prominent role in tissue damage during sepsis
[46]. KC is the murine equivalent of human IL-8 [34]. Like IL-8,
KC plays a significant role in neutrophil chemotaxis and activation
[34]. We found that serum KC levels in septic caPI3K Tg mice
were increased relative to the controls, but KC levels were
significantly lower in septic caPI3K Tg mice when compared to
WT CLP mice. We examined tissue myeloperoxidase (MPO)
levels as an index of tissue neutrophil infiltration and sequestration. Cardiomyocyte p110a expression resulted in a normalization
of MPO levels in the heart of CLP mice, indicating that transgene
expression prevented neutrophil sequestration in the heart during

sepsis. In the lung of caPI3K CLP mice we observed a pattern of
MPO activity that closely mirrored the serum KC response to
sepsis. Specifically, the expression of the p110a transgene
significantly attenuated sepsis induced neutrophil infiltration into
the lung. However, the increase in lung MPO, i.e. neutrophil
levels, did not result in increased apoptosis in the lung. Indeed,
caspase 3/7 and 8 activity were at control levels in the heart and
lung of caPI3k mice in response to sepsis. Interestingly, splenocyte
apoptosis, which is a hallmark of CLP sepsis, was increased in both
WT and caPI3K mice. This suggests that the beneficial effect of
cardiac specific expression of p110a does not prevent sepsis
induced splenocyte apoptosis. We have previously reported that
systemic activation of PI3K with a pharmacologic agent decreased
morbidity, prevented cardiac dysfunction and increased long term
survival in CLP sepsis in a manner very similar to that observed in
mice expressing the p110a transgene [11,18]. However, there was
one significant difference. In those studies we found that systemic
activation of PI3K prevented sepsis induced splenocyte apoptosis,
while at the same time maintaining cardiac function and
enhancing survival outcome. When taken together, these data
suggest that CLP sepsis does not mediate splenocyte apoptosis via
cardiac dysfunction, rather it is mediated through an alternative
mechanism. These data also suggest that transient and systemic
activation of PI3K/Akt [11] may be more beneficial in sepsis than
cardiac specific PI3K p110a activation.
Our data indicate that activation of a single isoform of PI3K
(p110a), in a single cell type (the cardiac myocyte), in a single
organ (heart), can have a profound effect on the morbidity and
mortality associated with fulminating sepsis. The precise mechanism(s) by which myocardial PI3K p110a activation induces such
dramatic effects at the systemic level are not entirely clear. It is
reasonable to speculate that maintaining left ventricular function
in sepsis/septic shock would have systemic benefits due to the
maintenance of peripheral vascular perfusion, blood pressure and
related issues. To the best of our knowledge, this is the first
demonstration of a causal relationship between PI3K/p110a, the
cardiac myocyte, cardiac function and survival outcome in sepsis.
These data have practical implications for the management of
sepsis, sepsis syndrome and septic shock. We have reported that
transient and systemic activation of PI3K by a pharmacologic
agent results in a maintenance of cardiovascular function and
decreased morbidity and mortality in sepsis [11,18]. The
decreased morbidity and mortality reported in that study is
consistent with the data observed in the current study, which
employed tissue specific genetic up regulation of PI3K p110a.
Therefore, transient pharmacologic up regulation of PI3K/Akt
signaling pathways may be beneficial in the prevention and/or
management of sepsis and septic sequelae.
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